Vickie Reed
Director/Board Member at EVOKE PHARMA, INC.
Net worth: - $ as of 31/03/2024
Profile
Presently, Vickie S. Reed occupies the position of Chief Financial & Accounting Officer at Mirati Therapeutics, Inc. She is also on the board of Evoke Pharma, Inc. Ms. Reed received an undergraduate degree from The University of Colorado.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EVOKE PHARMA, INC.
-.--% | 10/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Vickie Reed active positions
| Companies | Position | Start |
|---|---|---|
| EVOKE PHARMA, INC. | Director/Board Member | 13/05/2021 |
| DMK PHARMACEUTICALS CORPORATION | Director/Board Member | 24/05/2022 |
Former positions of Vickie Reed
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Director of Finance/CFO | 16/05/2022 |
| ZOGENIX, INC. | Director of Finance/CFO | 01/01/2022 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Vickie Reed
| The University of Colorado | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EVOKE PHARMA, INC. | Health Technology |
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Vickie Reed
